Biomaterials for intranasal and inhaled vaccine delivery.

Devorah CahnMayowa AmosuKatharina MaiselGregg A Duncan

Published in: Nature reviews bioengineering (2023)

Delivery of vaccines by nasal sprays may enable more robust, protective mucosal immune responses against infectious diseases, such as COVID-19, compared with intramuscular injection. In this Comment, we highlight how biomaterials can be designed to allow intranasal and inhaled vaccination.

Keyphrases

infectious diseases
immune response
cystic fibrosis
coronavirus disease
sars cov
tissue engineering
bone regeneration
ulcerative colitis
toll like receptor
respiratory syndrome coronavirus